NexImmune
Ms. Catterton joins NexImmune with over 20 years of experience in the biotechnology and pharmaceutical industry. During her career, she held positions in executive leadership, risk management, quality management systems, global compliance, design controls and regulatory affairs. Ms. Catterton has worked as an independent consultant for over 15 years to Fortune 500 companies, developing and implementing compliant solutions, dealing with FDA & third-party inspections, Consent Decree and Warning Letter responses and implementation.
This person is not in any offices
NexImmune
NexImmune is an emerging biopharmaceutical company advancing a new generation of immunotherapies based on our proprietary AIM™ technology.